Why the study?
To investigate 30-day complications, one-year all-cause mortality, and AF relapse following first-time catheter ablation for AF in patients ≥ 75 years of age compared to patients aged 65-74 years.
Does first-time catheter ablation for atrial fibrillation have similar safety and efficacy in patients ≥ 75 years compared to patients aged 65-74 years?
Does first-time catheter ablation for atrial fibrillation have similar safety and efficacy in patients ≥ 75 years compared to patients aged 65-74 years?
Catheter ablation for atrial fibrillation in selected patients ≥ 75 years of age has comparable periprocedural safety and one-year efficacy to patients aged 65-74 years.
Supports considering ablation in selected patients ≥75 years; leaves open generalizability and need for randomized data.
OBJECTIVES: To investigate complications within 30-days following first-time ablation for atrial fibrillation (AF), including a composite of cardiac tamponade, hematoma requiring intervention, stroke or death, in patients ≥ 75 years of age, compared to patients aged 65-74 years. In addition, one-year all-cause mortality and AF relapse were compared. METHODS & RESULTS: = 0.969). CONCLUSION: In patients ≥ 75 years of age selected for catheter ablation for AF, the incidence of periprocedural complications, as well as one-year freedom from AF showed no statistical difference, when compared to patients 65-74 years of age.
No takes yet. Share an insight, caveat, or question.
Nielsen et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: